San Diego’s Sequenom (NASDAQ: SQNM) says today it hopes to raise gross proceeds of $84 million from an underwritten public offering of 14 million shares of its common stock at a price of $6 a share. Jefferies & Company is the sole book-running manager for the offering. The company, which specializes in biomedical diagnostics, says it has granted the underwriters a 30-day option to purchase as much as 2.1 million additional shares to cover any over-allotments. The offering is expected to close Dec. 7. Sequenom share prices fell by more than 3 percent, or 22 cents, and were trading at about $6.60 at mid-day; trading was more than four times the recent average volume.

Comments | Reprints | Share:          

Bellevue, WA-based Intelius, an online background check and information commerce company, has withdrawn its IPO, according to a regulatory filing. The company filed for a $143 million initial public offering in January 2008, according to the Seattle PI. In a statement, Intelius said it did not appear that the public offering would be made in the foreseeable future. In August, the company was involved in a legal dispute, in which it agreed to pay a $1.3 million settlement.

Comments | Reprints | Share:          

Clinical Data (NASDAQ:CLDA), the Newton, MA-based drug developer, reports today that it has closed on the sale of 2.24 million shares of common stock. The stock offering brought in $32 million, of which the company plans to clear $30 million after expenses. The company is pursuing approval of its first drug, vilazodone, for treating depression. Last month, the FDA agreed to consider the company’s application for approval of the drug. Here’s a recent feature on Clinical Data’s big plans in the lucrative market for anti-depression pills.

Comments | Reprints | Share:          

It took awhile, but the San Diego solar energy planning, architectural, and cleantech firm Envision Solar International officially began trading on the over-the-counter bulletin board market, according to a statement yesterday. The founding CEO, Robert Noble, talked about the move at a reception in February. The company’s shares trade under the symbol EVSI.

Comments (1) | Reprints | Share:          

Monotype Imaging (NASDAQ: TYPE), the Woburn, MA-based maker of electronic fonts and text imaging software that went public last summer, announced last night that it’s planning a secondary public offering of 5 million shares of its common stock at $12.00 per share. The 170-employee company, the creator of famous fonts such as Times New Roman and Arial, competes with San Jose, CA-based Adobe Systems and Cambridge, MA-based Bitstream in the market for digital typefaces and software for text rendering on computers.

Comments | Reprints | Share:          

Burlington, MA-based speech software company Nuance Communications said today that it will sell 5,575,000 shares of common stock to the public at $18.15 per share in an offering that will close on June 10. If sole underwriter Thomas Weisel Partners exercises an option to buy additional shares, the offering could pull in as much as $115 million for the company, money it plans to use for including “working capital and to fund possible investments in and acquisitions of complementary businesses, partnerships, minority investments, products or technologies,” according to an announcement.

Comments | Reprints | Share:          

Waltham, MA-based e-mail marketing and survey firm Constant Contact yesterday filed an SEC registration statement saying it intends to sell more than 106,000 shares of common stock in a secondary offering. At the same time, Constant Contact stockholders—mostly venture firms looking for their exit—plan to sell some 4.3 million shares. At this morning’s stock price of $15.20, the sale would raise about $1.62 million for Constant Contact and roughly $65.1 million for its selling shareholders, who include Morgan Stanley Dean Witter Venture Partners, Longworth Venture Partners, Commonwealth Capital Ventures, and Greylock Partners.

Comments | Reprints | Share: